JY
LKFT

Jeff Yass’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Jeff Yass’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.5M Sell
449,100
-200
-0% -$5.68K ﹤0.01% 2939
2026
Q1 		$13.5M Buy
+449,300
New +$14.9M ﹤0.01% 2693
2025
Q3 		– Sell
-150,100
Closed -$4.2M – 12948
2025
Q2 		$4.2M Sell
150,100
-2,500
-2% -$67K ﹤0.01% 4306
2025
Q1 		$3.83M Buy
152,600
+103,300
+210% +$2.61M ﹤0.01% 4162
2024
Q4 		$1.36M Buy
49,300
+18,200
+59% +$507K ﹤0.01% 6205
2024
Q3 		$895K Buy
31,100
+11,900
+62% +$324K ﹤0.01% 7051
2024
Q2 		$476K Buy
19,200
+1,800
+10% +$51.1K ﹤0.01% 8376
2024
Q1 		$560K Sell
17,400
-65,900
-79% -$2.45M ﹤0.01% 8243
2023
Q4 		$3.39M Buy
83,300
+64,100
+334% +$2.36M ﹤0.01% 4372
2023
Q3 		$663K Sell
19,200
-74,400
-79% -$2.9M ﹤0.01% 7579
2023
Q2 		$3.81M Sell
93,600
-22,000
-19% -$897K ﹤0.01% 3969
2023
Q1 		$4.47M Buy
115,600
+12,100
+12% +$497K ﹤0.01% 3626
2022
Q4 		$4.59M Buy
103,500
+45,100
+77% +$1.9M ﹤0.01% 3372
2022
Q3 		$2.49M Buy
58,400
+8,100
+16% +$415K ﹤0.01% 4471
2022
Q2 		$2.81M Buy
50,300
+5,100
+11% +$302K ﹤0.01% 4208
2022
Q1 		$2.8M Buy
45,200
+31,600
+232% +$1.93M ﹤0.01% 4752
2021
Q4 		$750K Sell
13,600
-74,400
-85% -$3.88M ﹤0.01% 8065
2021
Q3 		$4.63M Sell
88,000
-700
-0.8% -$41.6K ﹤0.01% 4096
2021
Q2 		$6.11M Sell
88,700
-92,600
-51% -$7.06M ﹤0.01% 3653
2021
Q1 		$14M Buy
181,300
+109,400
+152% +$10.1M ﹤0.01% 2320
2020
Q4 		$7.12M Buy
71,900
+22,600
+46% +$2.76M ﹤0.01% 2916
2020
Q3 		$7M Sell
49,300
-11,000
-18% -$1.83M ﹤0.01% 2649
2020
Q2 		$11.9M Sell
60,300
-17,500
-22% -$3.62M ﹤0.01% 1940
2020
Q1 		$15.2M Sell
77,800
-16,400
-17% -$3.53M ﹤0.01% 1378
2019
Q4 		$19.5M Sell
94,200
-28,900
-23% -$5.34M 0.01% 1445
2019
Q3 		$18.8M Buy
123,100
+75,400
+158% +$12.4M 0.01% 1378
2019
Q2 		$6.15M Buy
47,700
+22,500
+89% +$2.67M ﹤0.01% 2442
2019
Q1 		$2.97M Buy
25,200
+19,800
+367% +$2M ﹤0.01% 3143
2018
Q4 		$495K Sell
5,400
-31,300
-85% -$3.17M ﹤0.01% 6051
2018
Q3 		$4.13M Sell
36,700
-7,600
-17% -$803K ﹤0.01% 2912
2018
Q2 		$4.08M Buy
44,300
+24,200
+120% +$2.35M ﹤0.01% 2975
2018
Q1 		$2M Buy
20,100
+14,200
+241% +$1.53M ﹤0.01% 3911
2017
Q4 		$553K Sell
5,900
-3,400
-37% -$322K ﹤0.01% 6446
2017
Q3 		$946K Buy
9,300
+900
+11% +$78.6K ﹤0.01% 5375
2017
Q2 		$643K Buy
+8,400
New +$707K ﹤0.01% 6158

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Jeff Yass's LKFT Position: Q2 2026 in Review

Jeff Yass increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 1,035% in Q2 2026, buying an estimated $3.93M and bringing the position to 151,886 shares worth $4.55M. The position accounts for ﹤0.01% of the portfolio, ranked #4802.

Jeff Yass first reported a position in LKFT in Q3 2016 and has held it in 30 quarters since. The position peaked at $8.58M in Q1 2021. 77 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Jeff Yass held 151,886 shares of Lakefront Biotherapeutics American Depositary Shares worth $4.55M as of Q2 2026.
  • Jeff Yass bought 138,499 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $3.93M.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #4802 holding.
  • Jeff Yass first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2016 and has held it in 30 quarters since.
  • Jeff Yass's Lakefront Biotherapeutics American Depositary Shares position peaked at $8.58M in Q1 2021.
  • 77 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.